ClinConnect ClinConnect Logo
Search / Trial NCT05847842

Comparison of Local Anesthetic Infiltration and Different Fascial Plane Blocks in Inguinal Hernia Repair

Launched by ESKISEHIR OSMANGAZI UNIVERSITY · May 4, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This clinical trial is studying different methods of pain management for patients undergoing surgery to repair an inguinal hernia, which is a common condition where tissue pushes through a weak spot in the abdominal muscles. The researchers are comparing three techniques: a local anesthetic injection directly into the surgery area, a quadratus lumborum block (QLB), and a transversus abdominis plane block (TAP). These methods will help reduce pain after surgery and improve the overall recovery experience for patients.

To participate in this trial, you need to be between the ages of 18 and 80 and scheduled for an elective surgery to repair a unilateral inguinal hernia using general anesthesia. You should generally be in good health according to the American Society of Anesthesiology's classification, which means you can have mild to moderate health conditions but not severe ones. If you have had previous hernia surgery, are taking certain blood-thinning medications, or have issues that make communication difficult, you may not be eligible. Participants will receive one of the pain management techniques before their surgery and will be monitored for pain levels and recovery quality afterward. This study aims to find the most effective way to manage pain after hernia repair surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who will undergo elective unilateral inguinal herniorrhaphy under general anesthesia
  • American Society of Anesthesiology (ASA) physical classification I-III
  • Exclusion Criteria:
  • Patients who will undergo laparoscopic surgery
  • Previous inguinal hernia repair surgery
  • A history of opioid use or pain management
  • Coagulopathy or anticoagulant use
  • Patients who have difficulty communicating or who are not cooperative

About Eskisehir Osmangazi University

Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.

Locations

Eskisehir, , Turkey

Eskişehir, , Turkey

Patients applied

0 patients applied

Trial Officials

Gulay Erdogan Kayhan, Prof Dr

Principal Investigator

Eskisehir Osmangazi University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported